Great Lakes Cancer Management Specialists

Immunotherapy-associated autoimmune hemolytic anemia

Uqba Khan, Farman Ali, Muhammad Khurram et al. · Journal for ImmunoTherapy of Cancer · 2017 · 75 citations · Full text

Medicine, Hematology, Oncology +17

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results

Paul G. Richardson, William Bensinger, Carol Ann Huff et al. · British Journal of Haematology · 2018 · 36 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature

Pat W. Whitworth, Peter D. Beitsch, James Pellicane et al. · JCO Precision Oncology · 2022 · 18 citations · Full text

Medicine, Oncology, Breast Oncology +15

Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer

Pat W. Whitworth, Peter D. Beitsch, James Pellicane et al. · Annals of Surgical Oncology · 2022 · 15 citations · Full text

Medicine, Oncology, Breast Oncology +14

Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy

Pat W. Whitworth, Peter D. Beitsch, Mary K. Murray et al. · JCO Precision Oncology · 2022 · 10 citations · Full text

Medicine, Cancer Biology, Oncology +17